Management of CAD in Patients with Active Cancer: the Interventional Cardiologists’ Perspective Dana Elena GizaKostas MarmagkiolisCezar Iliescu Cardio-Oncology (SA Francis, Section Editor) 09 May 2017 Article: 56
Transition of Care in Congenital Heart Disease: Ensuring the Proper Handoff Angela LeeBarbara BaileyErwin Oechslin Congenital Heart Disease (RA Krasuski, Section Editor) 05 May 2017 Article: 55
Endovascular Management of Massive and Submassive Acute Pulmonary Embolism: Current Trends in Risk Stratification and Catheter-Directed Therapies Ethan C. KosovaKush R. DesaiDaniel R. Schimmel Peripheral Vascular Disease (CJ Cooper and R Gupta, Section Editors) 02 May 2017 Article: 54
Exploring the Pathophysiology of Takotsubo Cardiomyopathy Wengen ChenVasken Dilsizian Nuclear Cardiology (V Dilsizian, Section Editor) 24 April 2017 Article: 53
Targeting LDL Cholesterol: Beyond Absolute Goals Toward Personalized Risk Morton LeibowitzChandra Cohen-StaviRan D. Balicer Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor) 21 April 2017 Article: 52
The Vascular Wall: a Plastic Hub of Activity in Cardiovascular Homeostasis and Disease Cassandra P. AwgulewitschLinh T. TrinhAntonis K. Hatzopoulos Regenerative Medicine (SM Wu, Section Editor) 21 April 2017 Article: 51
Current Role of Blood and Urine Biomarkers in the Clinical Care of Adults with Congenital Heart Disease Saurabh RajpalLaith AlshawabkehAlexander R. Opotowsky Congenital Heart Disease (RA Krasuski, Section Editor) 21 April 2017 Article: 50
Management of Dyslipidemias in Europe and the USA: Same Evidence, Different Conclusions? Can We Find Common Ground? Ian M. GrahamAlberico L. Catapano Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor) 21 April 2017 Article: 49
Lipid Biomarkers for Risk Assessment in Acute Coronary Syndromes Jeffrey W. MeeusenLeslie J. DonatoAllan S. Jaffe Management of Acute Coronary Syndromes (AS Jaffe, Section Editor) 21 April 2017 Article: 48
Does Supplementation with Omega-3 PUFAs Add to the Prevention of Cardiovascular Disease? Evangelos C. RizosMoses S. Elisaf Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor) 21 April 2017 Article: 47